Dysregulation of signaling pathway | Molecular mechanism | Proposed function | References |
---|---|---|---|
Wnt/β-catenin signaling pathway | Competitive binding E-cadherin | Release of β-catenin from the E-cadherin/β-catenin complex | [22] |
Phosphorylation of LRP6 | Activation of Dvl | [34] | |
Phosphorylation of Akt | Inactivation of GSK-3β and activation of downstream β-catenin | [37] | |
Direct binding GSK-3β | Degradation of GSK-3β and activation of downstream β-catenin | [38] | |
P13K/Akt signaling pathway | Phosphorylation of EGFR | Activation of the P13K p85 subunit and downstream Akt | |
Interaction with c-met | Activation of P13K/Akt, the downstream β-catenin and NF-κB | [21] | |
Interaction with P13K p85 | Activation of the P13K p85 subunit and downstream Akt | ||
NF-κB signaling pathway | Activation of MEK/ERK | Phosphorylation of p65, induced the release of IL-8 | |
Autophosphorylation of TAK1 Synergy with phosphorylation of MEKK3 | Recruitment and activation of IKK complex | [60] | |
Shh signaling pathway | Activation of NF-κB | Overexpression of Shh |  |
JNK signaling pathway | Activation of TNF homolog Eiger or overexpression of Rhol | Upregulation of JNK signaling, induced apoptosis and compensatory proliferation | |
JAK/STAT3 signaling pathway | Induced IL-6, IL-10 | Phosphorylation of STAT3, nuclear translocation of STAT3 | |
ERK/MAPK signaling pathway | Interaction with SHP2, Grb2 and Crk/Crk-L | Activation of ERK/MAPK signaling, induced cell scattering |